Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands |
Total |
Ordinary Shares |
Additional paid in capital |
Accumulated deficit |
Accumulated other comprehensive income |
Treasury Stock |
| Beginning balance (in shares) at Dec. 31, 2023 |
|
977,151,270
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 796,118
|
$ 6
|
$ 2,975,302
|
$ (2,195,980)
|
$ 37,626
|
$ (20,836)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
1,046,440
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
0
|
|
|
|
|
| Exercise of share options |
0
|
$ 0
|
0
|
|
|
|
| Share-based compensation |
17,980
|
|
17,980
|
|
|
|
| Net loss |
(53,471)
|
|
|
(53,471)
|
|
|
| Foreign currency translation |
1,542
|
|
|
|
1,542
|
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
978,197,710
|
|
|
|
|
| Ending balance at Mar. 31, 2024 |
762,169
|
$ 6
|
2,993,282
|
(2,249,451)
|
39,168
|
$ (20,836)
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
|
|
|
|
(4,912,200)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
977,151,270
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
796,118
|
$ 6
|
2,975,302
|
(2,195,980)
|
37,626
|
$ (20,836)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(175,419)
|
|
|
|
|
|
| Foreign currency translation |
(9,356)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
989,268,370
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
667,669
|
$ 6
|
3,031,628
|
(2,371,399)
|
28,270
|
$ (20,836)
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
|
(4,912,200)
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
978,197,710
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
762,169
|
$ 6
|
2,993,282
|
(2,249,451)
|
39,168
|
$ (20,836)
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
8,087,630
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
25,000
|
|
|
|
|
| Exercise of share options |
44
|
$ 0
|
44
|
|
|
|
| Share-based compensation |
18,638
|
|
18,638
|
|
|
|
| Net loss |
(80,277)
|
|
|
(80,277)
|
|
|
| Foreign currency translation |
3,605
|
|
|
|
3,605
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
986,310,340
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
704,179
|
$ 6
|
3,011,964
|
(2,329,728)
|
42,773
|
$ (20,836)
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
393,850
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
2,564,180
|
|
|
|
|
| Exercise of share options |
2,869
|
$ 0
|
2,869
|
|
|
|
| Share-based compensation |
16,795
|
|
16,795
|
|
|
|
| Net loss |
(41,671)
|
|
|
(41,671)
|
|
|
| Foreign currency translation |
(14,503)
|
|
|
|
(14,503)
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
989,268,370
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
$ 667,669
|
$ 6
|
3,031,628
|
(2,371,399)
|
28,270
|
$ (20,836)
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
|
(4,912,200)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
1,077,702,540
|
1,082,614,740
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 840,898
|
$ 7
|
3,264,295
|
(2,453,083)
|
50,515
|
$ (20,836)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
(4,912,200)
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
137,540
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
$ 0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
6,324,120
|
|
|
|
|
| Exercise of share options |
3,733
|
$ 0
|
3,733
|
|
|
|
| Issuance cost of the follow-on public offering |
(28)
|
|
(28)
|
|
|
|
| Share-based compensation |
15,800
|
|
15,800
|
|
|
|
| Net loss |
(48,438)
|
|
|
(48,438)
|
|
|
| Foreign currency translation |
(1,212)
|
|
|
|
(1,212)
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
1,089,076,400
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
$ 810,753
|
$ 7
|
3,283,800
|
(2,501,521)
|
49,303
|
$ (20,836)
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
(4,912,200)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
1,077,702,540
|
1,082,614,740
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 840,898
|
$ 7
|
3,264,295
|
(2,453,083)
|
50,515
|
$ (20,836)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
(4,912,200)
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
$ (125,128)
|
|
|
|
|
|
| Foreign currency translation |
$ (10,870)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
1,105,865,950
|
1,113,299,160
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 759,945
|
$ 7
|
3,327,557
|
(2,578,211)
|
39,645
|
$ (29,053)
|
| Ending balance (in shares) at Sep. 30, 2025 |
(7,433,210)
|
|
|
|
|
(7,433,210)
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
1,089,076,400
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
$ 810,753
|
$ 7
|
3,283,800
|
(2,501,521)
|
49,303
|
$ (20,836)
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
(4,912,200)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
9,698,120
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
5,258,390
|
|
|
|
|
| Exercise of share options |
7,718
|
$ 0
|
7,718
|
|
|
|
| Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares) |
|
|
|
|
|
(7,820)
|
| Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation |
(27)
|
|
|
|
|
$ (27)
|
| Share-based compensation |
16,973
|
|
16,973
|
|
|
|
| Net loss |
(40,727)
|
|
|
(40,727)
|
|
|
| Foreign currency translation |
(2,955)
|
|
|
|
(2,955)
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
1,104,032,910
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
791,735
|
$ 7
|
3,308,491
|
(2,542,248)
|
46,348
|
$ (20,863)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
|
(4,920,020)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares (in shares) |
|
593,670
|
|
|
|
|
| Issuance of ordinary shares upon vesting of restricted shares |
0
|
$ 0
|
0
|
|
|
|
| Exercise of share options (in shares) |
|
8,672,580
|
|
|
|
|
| Exercise of share options |
2,143
|
$ 0
|
2,143
|
|
|
|
| Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares) |
|
|
|
|
|
(2,513,190)
|
| Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation |
(8,190)
|
|
|
|
|
$ (8,190)
|
| Share-based compensation |
16,923
|
|
16,923
|
|
|
|
| Net loss |
(35,963)
|
|
|
(35,963)
|
|
|
| Foreign currency translation |
$ (6,703)
|
|
|
|
(6,703)
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
1,105,865,950
|
1,113,299,160
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 759,945
|
$ 7
|
$ 3,327,557
|
$ (2,578,211)
|
$ 39,645
|
$ (29,053)
|
| Ending balance (in shares) at Sep. 30, 2025 |
(7,433,210)
|
|
|
|
|
(7,433,210)
|